Enquanto o presidente americano Donald Trump e seus assessores começam a avaliar substitutos para o presidente do Federal ...

Complete Novo Nordisk A/S ADR stock information by Barron's. View real-time NVO stock price and news, along with industry-best analysis.

The chief executive of UniCredit said in a newspaper interview the Italian bank was likely to withdraw its offer for smaller peer Banco BPM. Andrea Orcel told daily La Repubblica that his bank ...

Novo Nordisk sees the obesity drug market expanding to $100 billion by 2030. With promising new treatments in the pipeline, 24/7 Wall St. projects huge upside through the end of the decade.

Novo Nordisk has taken initiatives to accelerate target discovery by implementing AI/ML technologies into genetic and human-centric in vitro models. Given the significant costs associated with drug ...

It wasn't so long ago that Novo Nordisk (NVO 1.18%), a Denmark-based pharmaceutical company, seemed to be firing on all cylinders. However, the past year has been challenging for the drugmaker.

Novo Nordisk dished out an up-front payment of $200 million (not to mention potential milestone payments of up to $1.8 billion) to acquire UBT251, a triple agonist -- that is, a medicine that ...

The move marks a significant step as governments across Europe move to unload their crisis-era bailout positions.

The deal is expected to be completed in the first half of 2026, following consultations with employee representative bodies.

Attempts to merge European banks are becoming more common. Most recent deals, though, will require a major stakeholder to be dragged kicking and screaming — be it the target, a national government, or ...

Novo was originally expecting the trial to show 25%-plus weight loss in participants (compared to 15% with Wegovy). However, they “only” hit 22.7%. As a result, the share price dropped by 19%.